A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma

Amandeep S. Taggar, Paveen Mann, Michael R. Folkert, Shahdrad Aliakbari, Sten D. Myrehaug, Laura A. Dawson

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose: To conduct a systematic review evaluating the impact of high dose rate (HDR) intraluminal brachytherapy (ILBT) in the management of malignant biliary obstruction and cholangiocarcinoma with specific focus on stent patency, clinical outcomes and toxicities. Methods and materials: A review of published articles was conducted using Medline, Embase and Cochrane databases using the search terms “bile duct carcinoma” or “cholangiocarcinoma” or “bile duct neoplasms” in combination with “brachytherapy” or “high dose rate brachytherapy” or “HDR brachytherapy”. Studies published in English and reporting outcomes of ≥10 patients were included in the review. Only the most recent experience was included if same patients were included in sequential publications. Results: Seventeen studies were identified that met the inclusion criteria. Significant heterogeneity was observed in treatment regimens, which included use of surgery, external beam radiation (EBRT), and/or intra-arterial and intravenous chemotherapy in conjunction with ILBT. Nevertheless, among the included studies, use of ILBT appeared to result in longer duration of stent patency: 10 months with ILBT compared to 4–6 months without ILBT. A trend was observed towards prolonged local control and improved complete and partial response rates in patients treated with ILBT with or without EBRT. Weighted mean overall survival of patients treated with ILBT alone was 11.8 months compared to 10.5 months for those that received EBRT +/− chemotherapy in addition to ILBT. The included studies reported low complication rates and toxicity related to ILBT. Conclusion: Brachytherapy can be an effective and safe tool in the management of malignant biliary tract obstruction in combination with stenting. Both retrospective and prospective studies have suggested improved outcomes when HDR ILBT is combined with percutaneous stenting.

Original languageEnglish (US)
Pages (from-to)60-74
Number of pages15
JournalRadiotherapy and Oncology
Volume165
DOIs
StatePublished - Dec 2021

Keywords

  • Cholangiocarcinoma
  • High-dose rate
  • Intraluminal brachytherapy
  • Malignant biliary tract obstruction

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma'. Together they form a unique fingerprint.

Cite this